Oladapo Yeku, MD, PhD

Dr. Oladapo Yeku is currently a Medical Oncology Fellow at Memorial Sloan Kettering Cancer Center. He is a laboratory research track fellow and will be investigating adoptive T Cell therapy for ovarian cancer. He graduated summa cum laude with a B.S degree in Biology from Medgar Evers College and was accepted to the Medical Scientist Training Program (MSTP) at Stony Brook University where he earned his combined M.D/Ph.D. degree. While there, he wrote for and was successfully awarded an F31 grant to fund his research. After completing his Internal Medicine Residency at University of Pittsburgh Medical Center, he was accepted to Memorial Sloan Kettering Cancer Center. His current research interests involve the use of genetically engineered T cells to target MUC-16ecto expressed on ovarian cancer cells. Given the promising preclinical studies, this research has led to a phase I clinical trial using this technology for patients with advanced ovarian cancer. He will analyze the patient samples for these modified T cells and further characterize the tumor microenvironment.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]